Technical Guidelines for Integrated Disease Surveillance ... - PHRplus

More documents

Recommendations

Info

Annex 16Quarterly Report on New and Recurrent Cases ofBuruli Ulcer (BU 03)Buruli ulcerPatients registered during ___Qtr of _____Name of district: _________________________ Number of district: ______________________________Name of officer completing this form:_______________________________________________________Title:___________________________________Date of completion of this form (dd/mm/yy): ___/___/___Address:_____________________________________________________________________________________________________________________________________________________________________Tel:______________________________________Fax:________________________________________Email: _______________________________________________________________________________1. New and recurrent casesNewRecurrentLaboratory confirmation No laboratory confirmation Sub-total Total49 yrs 49 yrsM F M F M F M F M F M F M F M F2. Clinical forms of new and recurrent casesNodulePapule Plaque Oedema Ulcer Osteomyelitis Mixed TotalNewRecurrent3. Disabilities in new and recurrent casesYesDisability presentNoTotalNewRecurrentAnnex 16: Quarterly Report on New and Recurrent Cases of Buruli Ulcer (BU 03)169
Page 3:
Technical Guidelines forIntegrated
Page 6 and 7:
3.3.1 Review the updated charts, ta
Page 8 and 9:
7.1.2 Monitor timeliness and comple
Page 10 and 11:
List of TablesTable 1: Surveillance
Page 13:
AcronymsAFROAFPAIDSCBSCBSWCDCDHMTE-
Page 18 and 19:
An ill person presents to medical a
Page 20 and 21:
How are surveillance functions desc
Page 22 and 23:
4.0 Investigate** 5.0 Respond 6.0 P
Page 24 and 25:
National4.0 Investigate** 5.0 Respo
Page 26 and 27:
In general, the health of Ghanaians
Page 28 and 29:
How does Ghana’s MOH/GHS support
Page 30 and 31:
1.0 Identify Cases of Priority Dise
Page 32 and 33:
1.2 Improve district procedures for
Page 35 and 36:
Section 2Report Priority Diseases a
Page 37 and 38:
Name of diseaseRoutine summary repo
Page 39 and 40:
Identify and train CBS volunteers o
Page 41:
Clinicians, ward nurses or other re
Page 44 and 45:
3.0 Analyse DataAnalysing trends of
Page 46 and 47:
3. Label all the rows and columns,
Page 48 and 49:
Figure 4: Meningitis cases from Bol
Page 50 and 51:
The first step in analysing data by
Page 52 and 53:
3.2.3.3 Calculate case fatality rat
Page 54 and 55:
Table 6: Alert and epidemic/action
Page 56 and 57:
3.4 Use the analysis results to imp
Page 58 and 59:
4.0 Investigate Reported Outbreaks
Page 60 and 61:
4.4 Prepare to conduct an investiga
Page 62 and 63:
Review laboratory results with the
Page 64 and 65:
Draw a histogram representing the c
Page 66 and 67:
If the shape of the curve suddenly
Page 68 and 69:
5.0 Prepare and Respond to Outbreak
Page 70 and 71:
Periodically review and update othe
Page 72 and 73:
3. Select appropriate communication
Page 74 and 75:
Improve safe disposal of human wast
Page 76 and 77:
Table 7: Daily water needs per pers
Page 78 and 79:
Recommendations for improving epide
Page 80 and 81:
6.0 Provide FeedbackData are report
Page 82 and 83:
The newsletter can be produced simp
Page 84 and 85:
7.0 Evaluate and Improve Surveillan
Page 86 and 87:
Table 8 lists possible indicators t
Page 88 and 89:
Priority diseases are recorded in t
Page 90 and 91:
Indicators for measuring quality of
Page 93 and 94:
Section 8Community-based Surveillan
Page 95 and 96:
members to take action in the event
Page 97 and 98:
Participate in information dissemin
Page 99 and 100:
Section 9Summary Guidelines for Spe
Page 101 and 102:
Analyse and interpretdataReferenceT
Page 103 and 104:
Buruli UlcerBackground Buruli ulce
Page 105 and 106:
Cholera may cause severe dehydratio
Page 107 and 108:
Respond to epidemicthresholdIf a su
Page 109 and 110:
In Ghana, the disease was endemic i
Page 111 and 112:
ReferenceA guide to eliminating lep
Page 113 and 114:
Promote environmental sanitation: c
Page 115 and 116:
Surveillance goal Use a rapid late
Page 117 and 118:
OnchocerciasisBackground Filarial
Page 119 and 120:
Poliomyelitis (Acute flaccid paraly
Page 122 and 123:
Public health action Conduct activ
Page 124 and 125:
The global HIV pandemic has been a
Page 126 and 127:
Respond toepidemicAnalyse and inter
Page 128 and 129:
Public health action Case finding
Page 131 and 132: Annex 1Using Assessment Results to
Page 133: Tally, compile and report summary t
Page 136 and 137: Diseases of special public health f
Page 138 and 139: Pneumonia in childrenless than 5 ye
Page 140 and 141: Other diseases of public health imp
Page 143 and 144: Annex 5Laboratory Tests for Confirm
Page 145 and 146: Suspected disease orconditionCholer
Page 147 and 148: Suspected disease orconditionDiagno
Page 153: Annex 6List of Laboratories for Con
Page 157 and 158: Annex 8Case-based Surveillance Repo
Page 159 and 160: If laboratory specimen collectedFor
Page 161: 16. When the investigation of the c
Page 164 and 165: (For reporting from health facility
Page 166 and 167: 13. For vaccine-preventable disease
Page 169 and 170: Annex 11Total Number of Patients Se
Page 171: Annex 12Year ___________ Quarter __
Page 174 and 175: Analysis, interpretations, comments
Page 176 and 177: C. Location of Lesion(s)19. Upper l
Page 179 and 180: Annex 15Monthly Registration of Bur
Page 181: Classification a Location of Lesion
Page 187: Annex 18Sample Grid for Time Analys
Page 190 and 191: Comparing inpatient and outpatient
Page 192 and 193: No. of casesactually identified(7)D
Page 195 and 196: Annex 21Case Investigation Form - N
Page 197 and 198: Annex 22Case Investigation Form - A
Page 199 and 200: Annex 23Case Investigation Form - G
Page 201 and 202: Annex 23: Case Investigation Form -
Page 203: Annex 24Checklist of Laboratory Sup
Page 206 and 207: Antibiotics recommended for treatme
Page 208 and 209: Reassess the patient after the firs
Page 210 and 211: Other recommended antibiotics to tr
Page 213 and 214: Annex 27Conducting a Register Revie
Page 215 and 216: Annex 28Sample Messages for Communi
Page 217 and 218: Clean drinking water and storageCom
Page 219: Annex 29Planning an Emergency Immun
Page 222 and 223: 6. If the vaccine requires a diluen
Page 225 and 226: Annex 32District Outbreak Report Fo
Page 227 and 228: Annex 33Self-evaluation of the Time
Page 229: Annex 34Record of Reports ReceivedD
Page 232 and 233:
Health facility:___________________
Page 234 and 235:
Technical Guidelines for Integrated
Page 236:
SupervisionTrainingResources andper
show all

Technical Guidelines for Integrated Disease Surveillance ... - PHRplus

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?